232 related articles for article (PubMed ID: 24145016)
1. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay quantifying olaparib in human plasma.
Nijenhuis CM; Lucas L; Rosing H; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():121-5. PubMed ID: 24145016
[TBL] [Abstract][Full Text] [Related]
2. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay quantifying vemurafenib in human plasma.
Nijenhuis CM; Rosing H; Schellens JH; Beijnen JH
J Pharm Biomed Anal; 2014 Jan; 88():630-5. PubMed ID: 24216282
[TBL] [Abstract][Full Text] [Related]
3. Gender-dependent pharmacokinetics of olaparib in rats determined by ultra-high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Su G; Qin L; Su X; Tao C; Wei Y
Biomed Chromatogr; 2020 Mar; 34(3):e4791. PubMed ID: 31899538
[TBL] [Abstract][Full Text] [Related]
4. Liquid chromatography-tandem mass spectrometric assay for the PARP-1 inhibitor olaparib in combination with the nitrogen mustard melphalan in human plasma.
Sparidans RW; Martens I; Valkenburg-van Iersel LB; den Hartigh J; Schellens JH; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(21):1851-6. PubMed ID: 21622034
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a high-performance liquid chromatography-tandem mass spectrometry assay for the quantification of Dexamphetamine in human plasma.
Herbrink M; Thijssen B; Hillebrand MJX; Rosing H; Schellens JHM; Nuijen B; Beijnen JH
J Pharm Biomed Anal; 2018 Jan; 148():259-264. PubMed ID: 29059615
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous quantification of dabrafenib and trametinib in human plasma using high-performance liquid chromatography-tandem mass spectrometry.
Nijenhuis CM; Haverkate H; Rosing H; Schellens JH; Beijnen JH
J Pharm Biomed Anal; 2016 Jun; 125():270-9. PubMed ID: 27058232
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a high-performance liquid chromatography method for the quantitation of intracellular PARP inhibitor Olaparib in cancer cells.
Daumar P; Dufour R; Dubois C; Penault-Llorca F; Bamdad M; Mounetou E
J Pharm Biomed Anal; 2018 Apr; 152():74-80. PubMed ID: 29414021
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a highly rapid and sensitive LC-MS/MS method for determination of SZ-685C, an investigational marine anticancer agent, in rat plasma--application to a pharmacokinetic study in rats.
Chen JY; Wang XD; Zhong GP; Qin XL; Li JL; Huang ZY; Zhu X; Li MF; Huang M
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2127-34. PubMed ID: 21703949
[TBL] [Abstract][Full Text] [Related]
9. Highly sensitive method for the determination of a novel triple kinase inhibitor with anti-cancer activity, JI-101, in rat plasma by liquid chromatography-electrospray ionization tandem mass spectrometry: application to a pharmacokinetic study.
Gurav SD; Gilibili RR; Jeniffer S; Giri S; Srinivas NR; Mullangi R
Biomed Chromatogr; 2011 Jul; 25(7):794-800. PubMed ID: 20872957
[TBL] [Abstract][Full Text] [Related]
10. Development and Validation of a Simultaneous Quantification Method of Ruxolitinib, Vismodegib, Olaparib, and Pazopanib in Human Plasma Using Liquid Chromatography Coupled With Tandem Mass Spectrometry.
Pressiat C; Huynh HH; Plé A; Sauvageon H; Madelaine I; Chougnet C; Le Maignan C; Mourah S; Goldwirt L
Ther Drug Monit; 2018 Jun; 40(3):337-343. PubMed ID: 29474275
[TBL] [Abstract][Full Text] [Related]
11. Determination of unbound vismodegib (GDC-0449) concentration in human plasma using rapid equilibrium dialysis followed by solid phase extraction and high-performance liquid chromatography coupled to mass spectrometry.
Deng Y; Wong H; Graham RA; Liu W; Shen HS; Shi Y; Wang L; Meng M; Malhi V; Ding X; Dean B
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jul; 879(22):2119-26. PubMed ID: 21704573
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of an LC-ESI-MS method for quantitative determination of aripiprazole in human plasma and an application to pharmacokinetic study.
Ravinder S; Bapuji AT; Mukkanti K; Raju DR; Ravikiran HL; Reddy DC
J Chromatogr Sci; 2012; 50(10):893-901. PubMed ID: 22767645
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of an integrated LC-MS/MS assay for therapeutic drug monitoring of five PARP-inhibitors.
Bruin MAC; de Vries N; Lucas L; Rosing H; Huitema ADR; Beijnen JH
J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Feb; 1138():121925. PubMed ID: 31915109
[TBL] [Abstract][Full Text] [Related]
14. Improved quantitative method for fludarabine in human plasma by liquid chromatography and tandem mass spectrometry.
Ng ES; Kangarloo SB; Daly A
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 931():103-10. PubMed ID: 23777614
[TBL] [Abstract][Full Text] [Related]
15. LC-MS-MS determination of imatinib and N-desmethyl imatinib in human plasma.
Zhang Y; Qiang S; Yu Z; Zhang W; Xu Z; Yang L; Wen A; Hang T
J Chromatogr Sci; 2014 Apr; 52(4):344-50. PubMed ID: 23574742
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of goserelin in rabbit plasma.
Kim MK; Lee TH; Suh JH; Eom HY; Min JW; Yeom H; Kim U; Jung HJ; Cha KH; Choi YS; Youm JR; Han SB
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Aug; 878(24):2235-42. PubMed ID: 20655813
[TBL] [Abstract][Full Text] [Related]
17. A validated LC-MS/MS assay for the simultaneous determination of the anti-leukemic agent dasatinib and two pharmacologically active metabolites in human plasma: application to a clinical pharmacokinetic study.
Furlong MT; Agrawal S; Hawthorne D; Lago M; Unger S; Krueger L; Stouffer B
J Pharm Biomed Anal; 2012 Jan; 58():130-5. PubMed ID: 21982905
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a LC-MS/MS method with electrospray ionization for determination of LASSBio-579 in rat plasma.
Conrado DJ; Palma EC; Fraga CA; Barreiro EJ; Rates SM; Dalla Costa T
J Pharm Biomed Anal; 2007 Jan; 43(2):677-82. PubMed ID: 16979864
[TBL] [Abstract][Full Text] [Related]
19. Validated assay for the simultaneous determination of cortisol and budesonide in human plasma using ultra high performance liquid chromatography-tandem mass spectrometry.
Szeitz A; Manji J; Riggs KW; Thamboo A; Javer AR
J Pharm Biomed Anal; 2014 Mar; 90():198-206. PubMed ID: 24389462
[TBL] [Abstract][Full Text] [Related]
20. Validated LC-MS/MS assay for the quantitative determination of vardenafil in human plasma and its application to a pharmacokinetic study.
Lake ST; Altman PM; Vaisman J; Addison RS
Biomed Chromatogr; 2010 Aug; 24(8):846-51. PubMed ID: 20033891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
